Welcome to our dedicated page for Trulieve Cannabis news (Ticker: TCNNF), a resource for investors and traders seeking the latest updates and insights on Trulieve Cannabis stock.
Trulieve Cannabis Corp (TCNNF) provides comprehensive medical and recreational cannabis products through its vertically integrated operations across multiple U.S. states. This news hub offers investors and stakeholders direct access to official corporate announcements, financial disclosures, and operational updates.
Discover timely information about earnings reports, regulatory compliance milestones, dispensary expansions, and product innovations. Our curated collection ensures transparent tracking of Trulieve's market leadership in cultivation practices and retail operations within strictly regulated environments.
Key updates include strategic acquisitions, new market entries, sustainability initiatives, and advancements in medical cannabis research. All content originates from verified company communications to maintain accuracy and compliance with financial disclosure standards.
Bookmark this page for streamlined monitoring of TCNNF's operational developments and industry positioning. Check regularly for updates on one of the cannabis sector's most influential multi-state operators.
Trulieve Cannabis Corp. (OTCQX: TCNNF) announced it will hold its second quarter 2024 results conference call on August 6, 2024, at 8:30 AM Eastern Time. The call, led by CEO Kim Rivers and CFO Wes Getman, will review the company's financial and operating results for Q2 2024. Participants can join the call by dialing 1-844-824-3830 (North America) or 1-412-542-4136 (International), using the passcode 1732811. A live audio webcast and a replay will be available on Trulieve’s investor website.
Trulieve Cannabis Corp. (OTCQX: TCNNF), a leading U.S. cannabis company, announced the opening of a new medical cannabis dispensary in Homosassa, Florida. The grand opening is scheduled for July 5, 2024, and will include music, specials, discounts, and patient education registration opportunities. Located at 5679 S Suncoast Blvd, the dispensary will operate from 9 a.m. to 8:30 p.m. Monday to Saturday, and 11 a.m. to 8 p.m. on Sundays, offering walk-in and express pickup services.
The Homosassa location will feature a variety of Trulieve's in-house brands, such as Alchemy, Co2lors, and Cultivar Collection, along with partner brands like Alien Labs and Khalifa Kush, exclusive to Trulieve in Florida. Veterans receive a 20% discount, and first-time customers get a 60% discount. Trulieve also offers home delivery, online ordering, and in-store pickup across Florida.
Trulieve Cannabis Corp. (OTCQX: TCNNF) will open new medical cannabis dispensaries in Madison and Panama City, Florida, with grand opening celebrations on July 5th. These locations will expand patient access in Madison and Bay Counties, offering a range of in-house and partner cannabis brands. Both dispensaries will be open Monday through Sunday, providing walk-in and express pickup services. Trulieve continues to offer home delivery, online ordering, and a 20% discount for veterans. The new dispensaries will also support the #YesOn3 ballot initiative for adult cannabis use.
Trulieve Cannabis Corp. (CSE: TRUL, OTCQX: TCNNF) has announced the opening of its 200th dispensary in the U.S., located in Brooksville, Florida. The grand opening celebration is scheduled for June 14, featuring a ribbon-cutting ceremony, food trucks, music, giveaways, specials, and educational opportunities about the Smart and Safe Florida ballot initiative. CEO Kim Rivers highlighted the company's growth since 2016 and their dedication to expanding cannabis access. The new location will offer a variety of in-house and partner cannabis brands, including Alchemy, Co2lors, and Khalifa Kush, available exclusively at Trulieve. The dispensary will provide walk-in and express pickup services, and Trulieve continues to offer home delivery and online ordering options across Florida.
Trulieve Cannabis Corp. (CSE: TRUL, OTCQX: TCNNF) announced a settlement resolving active litigation. The agreement includes Trulieve acquiring Harvest of Ohio, adding medical cannabis dispensaries in Columbus and Beavercreek to its Ohio portfolio. The Athens dispensary will be rebranded under new ownership. Additionally, Harvest Grows and Harvest Processing, which operate a production facility in Ironton, will be sold to third parties, with Trulieve providing operational support. CEO Kim Rivers highlighted the strategic expansion and future service to both medical and adult-use customers.
Trulieve Cannabis Corp. announced the opening of a new medical cannabis dispensary in Stuart, Florida, with a grand opening celebration on May 17th. The new location will offer a wide variety of products and services, including Trulieve's branded products and partner brands exclusive to Trulieve in Florida. Trulieve continues to expand access to medical cannabis across the state, providing discounts to veterans and first-time customers.
Trulieve Cannabis Corp reported first quarter 2024 results with $298 million in revenue, up 4% sequentially, and a 58% gross margin. The company demonstrated strong cash flow from operations of $139 million and free cash flow of $124 million. Significant progress was made on the Smart and Safe Florida adult use initiative and federal rescheduling of cannabis to Schedule III. Trulieve opened three new dispensaries in Florida and ended the quarter with 31% of retail locations outside of the state. Recent developments include the inclusion of the Smart & Safe Florida initiative on the November 2024 election ballot and progress on federal rescheduling of cannabis to Schedule III. Trulieve's CEO highlighted the strong performance in the core business and future growth catalysts, positioning the company for continued success.
Trulieve Cannabis Corp. announced its participation in upcoming events in May 2024. The company will be represented at the 19th Annual Needham Technology, Media, & Consumer Conference on May 16 and the Canaccord Genuity 8th Annual Global Cannabis Conference on May 23. Details and links to the events can be accessed on the investor relations page.